Nuveen Asset Management LLC lowered its holdings in Azenta, Inc. (NASDAQ:AZTA – Get Rating) by 32.2% during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 193,199 shares of the company’s stock after selling 91,716 shares during the quarter. Nuveen Asset Management LLC’s holdings in Azenta were worth $8,281,000 as of its most recent SEC filing.
Several other large investors have also modified their holdings of the business. Signaturefd LLC grew its position in Azenta by 29.5% in the 3rd quarter. Signaturefd LLC now owns 1,349 shares of the company’s stock valued at $58,000 after acquiring an additional 307 shares in the last quarter. Bessemer Group Inc. grew its stake in shares of Azenta by 3.6% in the third quarter. Bessemer Group Inc. now owns 101,367 shares of the company’s stock worth $4,345,000 after acquiring an additional 3,502 shares in the last quarter. Congress Wealth Management LLC DE increased its position in shares of Azenta by 6.0% during the third quarter. Congress Wealth Management LLC DE now owns 132,734 shares of the company’s stock worth $5,689,000 after acquiring an additional 7,506 shares during the period. Artisan Partners Limited Partnership acquired a new stake in shares of Azenta in the second quarter valued at $221,422,000. Finally, Wipfli Financial Advisors LLC purchased a new position in Azenta in the third quarter valued at $32,000. Institutional investors and hedge funds own 96.42% of the company’s stock.
Analysts Set New Price Targets
AZTA has been the topic of several recent research reports. Stephens downgraded Azenta from an “overweight” rating to an “equal weight” rating and cut their price target for the stock from $65.00 to $60.00 in a report on Thursday, February 9th. TheStreet raised shares of Azenta from a “d+” rating to a “c-” rating in a report on Tuesday, December 13th. B. Riley lowered their price target on shares of Azenta from $77.00 to $68.00 and set a “buy” rating for the company in a report on Friday, February 10th. Finally, Needham & Company LLC reduced their price objective on shares of Azenta from $78.00 to $68.00 in a report on Thursday, February 9th. One research analyst has rated the stock with a hold rating and four have assigned a buy rating to the company. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $66.80.
Azenta Stock Down 3.3 %
Azenta (NASDAQ:AZTA – Get Rating) last issued its earnings results on Wednesday, February 8th. The company reported $0.12 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.05 by $0.07. Azenta had a net margin of 349.08% and a return on equity of 1.17%. The business had revenue of $178.00 million during the quarter, compared to analysts’ expectations of $181.38 million. During the same quarter in the prior year, the business posted $0.12 EPS. The company’s revenue for the quarter was up 27.1% on a year-over-year basis. On average, equities analysts anticipate that Azenta, Inc. will post 0.28 EPS for the current fiscal year.
Azenta Company Profile
Azenta, Inc is a provider of life sciences sample exploration and management solutions for the life sciences market. It operates through the Life Sciences Products and Life Sciences Services segments. The Life Sciences Products segment is involved in automated cold storage solutions for biological and chemical compound samples.
- Get a free copy of the StockNews.com research report on Azenta (AZTA)
- What the SVB Financial Collapse Means for U.S. Banks
- MarketBeat Week in Review – 3/6 – 3/10
- 2 Offshore Drilling Stocks Set to Extract Big Profits
- Three Staples Stocks With Double-Digit Upside Ahead
- Can Investors Trust Consumers to Lift American Outdoor Brands?
Want to see what other hedge funds are holding AZTA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Azenta, Inc. (NASDAQ:AZTA – Get Rating).
Receive News & Ratings for Azenta Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Azenta and related companies with MarketBeat.com's FREE daily email newsletter.